What is gain of function research? In simple terms, it refers to research that examines what happens when a biological organism, gene or system acquires a new ability or an existing function becomes stronger. The phrase is used across biology, but it has become especially controversial when scientists conduct experiments involving viruses and other infectious pathogens. Questions about laboratory safety, pandemic preparedness, COVID-19 origins and government-funded research have turned gain-of-function research into a major scientific and political issue.
Key Points Summary
╔════════════════════════════════════════════════════════════════════╗
║ – Gain-of-function research examines new or enhanced biological capabilities. ║
║ – The term covers much more than experiments involving dangerous viruses. ║
║ – Some pathogen studies can raise serious laboratory-safety concerns. ║
║ – Scientists debate whether the benefits of certain experiments justify their risks. ║
║ – COVID-19 brought gain-of-function research into mainstream public discussion. ║
║ – U.S. policy has tightened controls on research considered dangerously high-risk. ║
║ – Definitions remain crucial when evaluating claims about government-funded research. ║
╚════════════════════════════════════════════════════════════════════╝
What Is Gain of Function Research in Simple Terms?
Gain-of-function research involves studying a biological change that gives something a capability it previously lacked or enhances a capability it already possessed.
The concept can apply to genes, cells, microorganisms and other biological systems.
For instance, researchers might investigate a genetic mutation that allows an organism to survive under different environmental conditions. Scientists could also examine changes affecting how a microorganism interacts with cells or responds to an immune system.
These experiments can help researchers understand how particular genes and biological mechanisms work.
The term becomes much more sensitive when it is applied to infectious pathogens.
In those circumstances, scientists may study changes affecting characteristics such as transmission, replication, host range, immune response or resistance to treatments.
That does not mean every gain-of-function experiment makes a pathogen more dangerous.
Why Is It Called Gain of Function?
The name describes what happens biologically.
If an organism acquires a new characteristic, researchers can describe that change as a “gain” of biological function.
Imagine a microorganism that normally cannot survive under a particular condition. If a genetic change enables it to survive there, it has gained a capability.
Similarly, if a change increases an existing biological activity, that can also be considered a gain of function.
This scientific meaning is broader than the way the phrase is often used in political discussions.
When politicians, commentators and news reports discuss gain-of-function research, they are frequently talking about the narrower and more controversial issue of experiments involving infectious pathogens.
What Is the Purpose of Gain-of-Function Research?
Scientists conduct biological experiments to understand how organisms behave and why particular genetic changes matter.
In infectious-disease research, scientists may want to determine how mutations affect a pathogen.
Research questions can include whether a mutation changes how effectively a pathogen replicates, which species or cells it can infect, how the immune system responds to it or whether existing treatments remain effective.
The information can potentially contribute to:
- Understanding infectious diseases.
- Tracking biological mutations.
- Improving disease surveillance.
- Studying pathogen evolution.
- Identifying important genetic characteristics.
- Testing scientific hypotheses.
- Supporting vaccine and treatment research.
- Improving preparedness for future outbreaks.
The controversy begins when obtaining that knowledge requires an experiment that may itself create additional risk.
Why Is Gain-of-Function Research Considered Controversial?
The controversy can be summarized with one question: How much biological risk should society accept in exchange for scientific knowledge?
Some researchers argue that controlled experiments can provide valuable information about how infectious diseases behave and evolve.
Critics contend that certain experiments may create pathogens with characteristics that would make a laboratory accident unusually dangerous.
This creates a difficult risk-benefit calculation.
An experiment might produce valuable scientific information while simultaneously creating biological material that requires exceptionally careful containment.
The debate therefore focuses less on whether infectious-disease research is valuable and more on whether specific experiments are necessary and sufficiently safe.
Is All Gain-of-Function Research Dangerous?
No.
One of the biggest misconceptions surrounding the subject is that all gain-of-function research involves making deadly pathogens stronger.
The scientific concept is much broader.
Many biological changes classified as gains of function do not create extraordinary public-health risks.
Risk depends on factors such as:
- The organism being studied.
- The genetic change involved.
- Whether the organism causes disease.
- Whether transmissibility changes.
- Whether disease severity changes.
- The laboratory containment level.
- The possibility of accidental exposure.
- Whether safer experimental alternatives exist.
An experiment involving a harmless organism is fundamentally different from an experiment that could enhance a pathogen capable of causing severe disease.
What Is Dangerous Gain-of-Function Research?
“Dangerous gain-of-function research” refers more specifically to high-risk research involving infectious agents or toxins where experimental changes could increase characteristics capable of causing significant harm.
Potentially concerning outcomes could include increasing a pathogen’s ability to cause disease, spread between hosts, resist treatments or evade important biological defenses.
This distinction matters because the broad phrase “gain of function” and the narrower category of dangerous gain-of-function research should not automatically be treated as interchangeable.
Government policy generally focuses most heavily on experiments that present meaningful biosafety or biosecurity risks.
How Did COVID-19 Change the Gain-of-Function Debate?
Before COVID-19, gain-of-function research was primarily discussed among scientists, government officials and specialists in biosecurity.
The pandemic dramatically changed that.
Public attention turned toward research involving coronaviruses, including experiments conducted before the pandemic.
Questions about the origin of SARS-CoV-2 also produced intense scrutiny of laboratories in Wuhan, China, particularly the Wuhan Institute of Virology.
U.S.-connected funding for coronavirus research became another major point of controversy.
Debates followed over whether certain experiments involving bat coronaviruses should be described as gain-of-function research and whether applicable federal oversight standards were adequate.
As a result, a technical scientific term became part of everyday political discussion.
Does Gain-of-Function Research Explain the Origin of COVID-19?
The classification of a scientific experiment and the origin of a pandemic are two different questions.
Determining whether particular research qualifies as gain-of-function research does not, by itself, establish that the research caused COVID-19.
Likewise, discussions about possible laboratory-related origins do not automatically demonstrate that a gain-of-function experiment produced SARS-CoV-2.
The distinction is important because political discussions sometimes combine these issues.
Evidence about the origin of an outbreak must be evaluated separately from regulatory debates about how earlier research should have been categorized.
Why Are Anthony Fauci and Rand Paul Connected to the Debate?
Anthony Fauci and Sen. Rand Paul became closely associated with the gain-of-function controversy because of their repeated confrontations over coronavirus research and U.S. government funding.
Paul questioned whether research connected to Wuhan should have been considered gain-of-function research.
Fauci disputed characterizations of the research under the federal definitions relevant to their exchanges.
Their disagreements highlighted a larger problem surrounding the phrase itself.
“Gain of function” can have a broad scientific meaning, while federal policies can establish narrower definitions for deciding which experiments require additional oversight.
Therefore, arguments over whether a particular project constituted gain-of-function research can depend significantly on the definition being applied.
Why Definitions Are So Important
Understanding definitions is essential before evaluating claims about gain-of-function research.
There are several different questions that can easily become mixed together:
Was a biological function experimentally enhanced?
Was an infectious pathogen involved?
Did the experiment increase a dangerous characteristic?
Did the project fall under a particular government definition?
Was additional federal review required?
These questions are related, but they are not identical.
A biological experiment could potentially meet a broad scientific description of gain of function without necessarily falling within a narrower government category for dangerous research.
This is why sweeping claims about whether someone “did” or “did not” fund gain-of-function research can be incomplete without explaining the definition and policy involved.
What Are the Biggest Risks?
Accidental release is one of the most widely discussed risks surrounding research with dangerous pathogens.
High-containment laboratories use extensive safeguards to reduce the possibility of exposure or escape.
These measures can include controlled entry, protective equipment, specialized airflow systems, decontamination protocols and strict procedures for handling biological materials.
Nevertheless, no system operated by humans can completely eliminate the possibility of mistakes.
If an experiment creates a pathogen with significantly enhanced dangerous characteristics, critics argue that even a very small probability of escape deserves serious consideration because the consequences could be substantial.
What Is Dual-Use Research?
Another concern is known as dual-use research.
Dual-use research has legitimate scientific purposes but may also produce information, technology or biological materials that could potentially be misused.
For example, understanding how a pathogen overcomes a biological defense could help researchers design better countermeasures.
At the same time, that knowledge might theoretically provide information useful to someone seeking to cause harm.
Governments and research institutions therefore consider not only laboratory accidents but also the security implications of certain research.
Could Gain-of-Function Research Help Prevent Future Pandemics?
Supporters of carefully regulated pathogen research argue that it can contribute to pandemic preparedness.
Scientists may investigate biological changes that could emerge naturally and identify characteristics worth monitoring.
If researchers understand which mutations significantly change pathogen behavior, surveillance programs may be better positioned to recognize concerning developments.
Experimental findings can also contribute to broader research involving vaccines, therapeutics and immune responses.
Critics, however, question whether deliberately producing potentially dangerous characteristics is necessary to obtain that knowledge.
They argue that safer alternatives should be used whenever they can answer the same scientific questions.
Are There Alternatives to High-Risk Experiments?
Modern science provides researchers with several approaches that may reduce the need for certain dangerous experiments.
Depending on the research question, alternatives can include computer modeling, genomic analysis, studies of naturally occurring variants, noninfectious experimental systems and research involving safer organisms.
These methods cannot necessarily replace every laboratory experiment.
However, the availability of alternatives has become an important part of the debate.
Before approving potentially high-risk research, regulators and scientists can consider whether the expected information could be obtained through a less dangerous method.
What Is the Difference Between Gain of Function and Loss of Function?
Gain-of-function and loss-of-function research examine opposite biological effects.
A gain-of-function change produces a new capability or strengthens an existing one.
A loss-of-function change weakens or removes a biological capability.
Both are common concepts in genetics.
For example, scientists may disable a gene and observe what changes. If removing the gene causes a biological process to stop, researchers gain evidence about the gene’s normal role.
Conversely, researchers may study what happens when a gene becomes more active or produces a new effect.
Neither approach is inherently dangerous.
Risk depends on the biological system and the experiment being conducted.
Is Gain-of-Function Research the Same as Bioweapons Research?
No.
Gain-of-function research is not synonymous with biological-weapons research.
Scientific experiments can alter biological characteristics for legitimate purposes, including understanding disease and developing medical countermeasures.
Biological-weapons programs involve biological agents intended for hostile purposes.
The confusion partly comes from dual-use concerns.
Some techniques developed for legitimate research could theoretically be misused, which is why high-risk biological research can require both safety and security oversight.
Is Gain-of-Function Research Banned in the United States?
It is inaccurate to describe every form of gain-of-function research as banned in the United States.
The broad scientific concept encompasses many different kinds of experiments.
U.S. policy has instead focused increasingly on restricting or prohibiting categories of research considered especially dangerous.
The federal approach changed significantly in 2025, when the Trump administration moved to tighten restrictions surrounding dangerous gain-of-function research.
Federal health agencies subsequently took steps involving funding, oversight and reviews of covered research.
The distinction remains important: restrictions targeting dangerous pathogen research do not mean that every experiment involving a gain of biological function is prohibited.
Why Government Funding Matters
Federal funding gives the government significant influence over how research is conducted.
Agencies can establish conditions researchers and institutions must satisfy before receiving taxpayer money.
Those requirements can address laboratory safety, ethical standards, reporting, security and additional review for unusually risky experiments.
Funding becomes more complicated when research involves international partners.
Projects can include universities, nonprofit organizations, subcontractors and laboratories located in different countries.
Critics of previous oversight arrangements have argued that such structures can make transparency and accountability more difficult.
Supporters of international scientific collaboration note that infectious diseases cross borders and that global research networks can be important for identifying emerging threats.
The challenge is creating oversight strong enough to manage the additional risks.
Why Laboratory Safety Matters
Laboratory safety, or biosafety, involves procedures intended to prevent accidental exposure to or release of biological materials.
Different pathogens require different levels of containment.
Scientists working with potentially hazardous agents may need specialized facilities, protective equipment, restricted access and strict handling procedures.
But the gain-of-function debate raises a question beyond whether a laboratory is secure.
Critics ask whether certain experiments should be conducted at all, even when advanced containment is available.
That shifts the discussion from “Can this experiment be performed safely?” to “Is this experiment worth performing?”
What Is Biosecurity?
Biosafety and biosecurity are closely related but not identical.
Biosafety primarily focuses on preventing accidental harm.
Biosecurity also addresses deliberate misuse, unauthorized access, theft and other security risks involving biological materials or information.
High-risk pathogen research can involve both concerns.
A laboratory must protect workers and surrounding communities from accidents while also ensuring that sensitive materials and information are adequately secured.
As biotechnology becomes more powerful and accessible, biosecurity is likely to become an increasingly important part of scientific policy.
Why Gain-of-Function Research Still Matters in 2026
The debate is no longer solely about COVID-19.
Biotechnology is developing rapidly, giving researchers increasingly sophisticated capabilities to analyze and modify biological systems.
These advances could produce new vaccines, treatments and medical breakthroughs.
At the same time, greater technical capability creates new questions about oversight.
Governments must determine what types of research deserve additional scrutiny, who should conduct reviews, how international projects should be monitored and when an experiment’s potential risks outweigh its scientific benefits.
The decisions made today could shape biological research and pandemic preparedness for years.
How Should Claims About Gain-of-Function Research Be Evaluated?
When encountering a claim about gain-of-function research, readers should avoid relying on the label alone.
Instead, consider several basic questions.
What organism was being studied?
What modification was performed?
What characteristic changed?
Could the change increase danger to humans or animals?
What rules existed when the research occurred?
Did the research fall within the government’s applicable regulatory definition?
Was federal funding involved?
Answering these questions can provide a much clearer understanding than simply categorizing an experiment as “gain of function.”
The Bottom Line
So, what is gain of function research?
At its broadest level, it is research examining biological changes that create a new function or enhance an existing capability.
The term does not automatically mean scientists are making dangerous viruses.
The greatest controversy surrounds a much narrower group of experiments involving infectious pathogens whose characteristics could potentially be altered in ways that increase public-health or security risks.
COVID-19 brought these questions into mainstream American politics, but the implications extend far beyond one pandemic.
As biotechnology advances, policymakers and scientists will continue confronting the difficult balance between encouraging research that could protect public health and preventing experiments whose potential consequences may be too great.
Understanding that distinction is essential for anyone trying to make sense of the scientific and political debate surrounding gain-of-function research.
What do you think the right balance should be between scientific discovery and strict oversight of potentially dangerous pathogen research? Share your views in the comments and stay updated as the debate develops.